An amendment to an offering — the company changed its terms or corrected its filing.

Oxeia Biopharmaceuticals, Inc.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.